Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Beneficial effects of upadacitinib on alopecia areata associated with atopic dermatitis: A multicenter retrospective study
Andrea Chiricozzi, Anna Balato, Gabriella Fabbrocini, et al.
Journal of the American Academy of Dermatology (2023) Vol. 89, Iss. 6, pp. 1251-1253
Closed Access | Times Cited: 17

Showing 17 citing articles:

Innovative strategies for the discovery of new drugs against alopecia areata: taking aim at the immune system
Hongwei Guo, Zhiming Ye, Siqi Chen, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 11, pp. 1321-1338
Closed Access | Times Cited: 5
Complete response of extensive alopecia areata refractory to baricitinib after five months of treatment with upadacitinib
Francisco Javier De la Torre-Gomar, Juan Pablo Velasco‐Amador, Álvaro Prados‐Carmona, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 4
Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
Xin He, Dongyue Yang, Lingyao Lai, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 565-571
Open Access | Times Cited: 4
Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
D Brănişteanu, Antonia-Elena Huțanu, Daniel Brănișteanu, et al.
Diagnostics (2025) Vol. 15, Iss. 5, pp. 520-520
Open Access
Selective JAK 1 inhibition with upadacitinib as a potential treatment for coexistent severe atopic dermatitis and alopecia areata
Guilherme Muzy
Anais Brasileiros de Dermatologia (2024) Vol. 99, Iss. 3, pp. 483-484
Open Access | Times Cited: 2
Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
Mara Giavina‐Bianchi, Pedro Giavina‐Bianchi
Journal of Allergy and Clinical Immunology Global (2024) Vol. 3, Iss. 3, pp. 100269-100269
Open Access | Times Cited: 2
Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review
Carlo Perricone, Roberto Dal Pozzolo, Giacomo Cafaro, et al.
Reumatismo (2024)
Open Access | Times Cited: 2
Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
Zoé Apalla, Efterpi Zafiriou, Effimia Zagkliverinou, et al.
Dermatology Practical & Conceptual (2024) Vol. 14, Iss. 2, pp. e2024073-e2024073
Open Access | Times Cited: 1
Novel investigational drugs for alopecia areata and future perspectives
Ivana Chim, Ragini Ghiya, Rodney Sinclair, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 5, pp. 441-449
Closed Access | Times Cited: 1
Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata
Xiaolin Zhang, Yiqun Jiang
American Journal of Clinical Dermatology (2024)
Closed Access | Times Cited: 1
Infectious events in patients with alopecia areata treated with JAK inhibitors: low burden and minimal impact on persistence in treatment
Giacomo Caldarola, Lorenzo Maria Pinto, Francesco Bellinato, et al.
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 11, pp. 1483-1487
Closed Access
Upadacitinib for the management of severe alopecia areata in adolescent patients: a single-center retrospective study
Vincenzo Picone, Paola Nappa, Maddalena Napolitano, et al.
Clinical and Experimental Dermatology (2024)
Closed Access
Inibição seletiva de JAK 1 com upadacitinibe como tratamento potencial para dermatite atópica grave e alopecia areata concomitante
Guilherme Muzy
(2024) Vol. 99, Iss. 3, pp. 483-484
Open Access
Upadacitinib for the treatment of alopecia areata – A case report
Jui-Wen Yeh, Chao‐Chun Yang
Dermatologica Sinica (2023) Vol. 42, Iss. 2, pp. 150-151
Open Access | Times Cited: 1
Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
Ilaria Salvi, Aurora Parodi, Emanuele Cozzani, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Innovation in Alopecia Areata
Luiza Kalil, Brett King
Dermatologic Clinics (2024) Vol. 43, Iss. 1, pp. 27-33
Closed Access
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective
Alba Guglielmo, Maria Ludovica Deotto, Luigi Naldi, et al.
Dermatology Reports (2023)
Open Access
Page 1

Scroll to top